Results 51 to 60 of about 350,390 (302)
Frontiers in Pharmacology, 2020 Given the extreme importance of the current pandemic caused by COVID-19 and due to the fact that scientists agree that there is no identified treatment, this paper analyzes in detail the treatment of a severe COVID-19 patient with convalescent plasma and
Ying Wang, Yang Zhang, Qian Yu, Kun Zhu
doaj +1 more source
The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. [PDF]
, 2018 Feline infectious peritonitis (FIP) is a common and highly lethal coronavirus disease of domestic cats. Recent studies of diseases caused by several RNA viruses in people and other species indicate that antiviral therapy may be effective against FIP in ...
Bauer, K +7 more
core +1 more source
Frontiers in Endocrinology, 2022 Coronavirus disease 2019 (COVID-19) is a serious epidemic, characterized by potential mutation and can bring about poor vaccine efficiency. It is evidenced that patients with malignancies, including prostate cancer (PC), may be highly vulnerable to the ...
Yu Ye +6 more
doaj +1 more source
Antimicrobial Stewardship & Healthcare Epidemiology, 2023 Background: Prescribing errors related to the COVID-19 oral antiviral agent nirmatrelvir-ritonavir have been reported and are primarily due to improper renal dosing and significant drug–drug interactions.
Jenna Preusker +8 more
doaj +1 more source
Diagnosis and Treatment of Infectious Enteritis in Adult Ruminants. [PDF]
, 2018 Infectious enteritis in adult ruminants is often a result of 1 or more viral, bacterial, or parasitic pathogens. Diagnosis of etiologic agents causing enteritis is important when considering herd implications and zoonotic potential of some etiologies ...
Chigerwe, Munashe, Heller, Meera C
core +1 more source
Characteristics of the Coronavirus Disease 2019 and related Therapeutic Options
Molecular Therapy: Methods & Clinical Development, 2020 The coronavirus disease 2019 (COVID-19) is a new type of pneumonia caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. COVID-19 is affecting millions of patients, and the infected number keeps increasing.
Boxuan Huang +9 more
doaj +1 more source
Drug repositioning is an alternative for the treatment of coronavirus COVID-19
International Journal of Antimicrobial Agents, 2020 Given the extreme importance of the current pandemic caused by COVID-19, and as scientists agree there is no identified pharmacological treatment, where possible, therapeutic alternatives are raised through drug repositioning. This paper presents a selection of studies involving drugs from different pharmaceutical classes with activity against SARS-CoV-
Serafin, Marissa B. +5 more
openaire +2 more sources
Journal of Rawalpindi Medical College, 2020 Background: COVID-19 shows variability depending on ethnicity and environmental factors therefore one type of drug may not be effective in all the populations. Personalized medicine refers to tailoring the treatment in accordance with individual patients.
Manzoor Khan +5 more
doaj +1 more source
A mini-review on the current COVID-19 therapeutic strategies [PDF]
Chemical Review and Letters, 2020 The coronavirus outbreak (COVID-19) started in china, on 31 December 2019. COVID-19 is a severe acute respiratory syndrome. Research on COVID-19 treatment strategies for development of an effective drug therapy has attracted worldwide attention recently.
Samira Shafiee, Soodabeh Davaran
doaj +1 more source
The Impact of Covid-19 on Future Higher-Age Mortality [PDF]
, 2020 Covid-19 has predominantly affected mortality at high ages. It kills by inflaming and clogging the air sacs in the lungs, depriving the body of oxygen ‒ inducing hypoxia ‒ which closes down essential organs, in particular the heart, kidneys and liver ...
Blake, D. +3 more
core